7/12/2022 | BKHY | S&P upgrades Mednax
|
2/18/2022 | BKCVDDEMIGPV | Market Commentary: Junk secondary lower as investors flee risk ahead of long weekend; CSC down; Mednax active
|
2/3/2022 | BKCVDDEMIGPV | Market Commentary: Four junk issuers sell $4 billion; real money accounts sell in secondary; outflows top $4 billion
|
2/2/2022 | BKCVDDEMIGPV | Market Commentary: AMC, Mednax, Boyne sell new junk; volatility returns; Bausch gains; cruise lines improve
|
2/1/2022 | BKHY | S&P rates Mednax notes B+
|
2/1/2022 | BKHY | Moody's ups, rates Mednax notes Ba3
|
8/27/2021 | BK | Mednax cuts revolving commitments in half to $600 million
|
5/14/2021 | BKHY | S&P shifts Mednax view to positive
|
12/21/2020 | BKHY | Moody’s shifts Mednax view to positive
|
9/11/2020 | BKHY | Moody’s eyes Mednax for upgrade
|
6/5/2020 | BKBWDDHY | Mednax to use divestiture proceeds to reduce debt, keep leverage low
|
5/11/2020 | BKDDHY | S&P cuts Mednax
|
5/8/2020 | BKHY | Moody’s changes Mednax view to negative
|
4/14/2020 | BKDDHY | Moody’s acts on nine health staffing companies
|
3/31/2020 | BKHYIG | S&P cuts Mednax to BB-
|
2/24/2020 | BK | S&P trims California Resources
|
2/24/2020 | BKHYIG | S&P revises Mednax view to negative
|
2/21/2020 | BKHYIG | Moody’s reviews Mednax for trim
|
11/11/2019 | BKHYIG | Moody’s revises Mednax view to negative
|
10/28/2019 | BKHYIG | S&P trims Mednax
|
5/20/2019 | BKBWHYIG | Mednax expects ‘meaningful’ cash flow this year, will pay down debt
|
3/29/2019 | BK | Mednax reduces revolving facility to $1.2 billion, extends to 2024
|
2/20/2019 | BKCVDDEMIGPV | Market Commentary: Springleaf, Antero Midstream price; XPO in focus; Mednax trades up; Uniti down
|
2/19/2019 | BKCVDDEMIGPV | Market Commentary: XPO prices new offering, existing bonds decline; Mednax prices add-on; Windstream tanks
|
11/7/2018 | BKCVDDEMIGPV | Market Commentary: Mednax prices; HC2, LifePoint on tap; Dean Foods, Coty under pressure post-earnings
|
11/7/2018 | BKHYIG | S&P rates Mednax notes BBB-
|
11/7/2018 | BK | Mednax plans to repay some revolver debt using proceeds from notes
|
11/6/2018 | BKIG | S&P revises Mednax view to negative
|
6/13/2016 | BKIG | Moody’s: Mednax unaffected on acquisition
|
12/3/2015 | BKCVDDEMIGPV | Market Commentary: HCA, Aramark, Group 1 price deals; new bonds busy; Chesapeake off; funds gain $398 million
|
12/2/2015 | BKCVDDEMIGPV | Market Commentary: Ball brings three-part deal; new Ball bonds gain; Synovus, Churchill Downs also price
|
12/1/2015 | BKHY | S&P gives Mednax CCR, notes BBB-
|
12/1/2015 | BKHY | Moody’s rates Mednax CFR, notes Ba2
|
11/30/2015 | BKCVDDEMIGPV | Market Commentary: Market ends November quietly with no pricings; NGL, Mednax, Ball Corp., shopping deals
|
11/30/2015 | BK | Mednax to pay down revolver with some proceeds of note offering
|
6/9/2015 | BK | Mednax expands credit facility by $400 million, may increase it more
|
11/26/2012 | BK | Mednax amends credit agreement for $800 million revolver due 2017
|
10/24/2011 | BK | Mednax closes expanded $500 million facility due in 2016 via 10 banks
|